Skip to content

Evaluation of Hydrogel dressing in treatment of Diabetic foot Ulcer

Evaluation of Efficacy of Tebaderm Wound Dressing vs. Moist Wound Dressing in the Treatment of Diabetic Wounds in a Randomized Clinical Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170612034485N1
Enrollment
60
Registered
2018-01-03
Start date
2017-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic diabetic foot Ulcer. Type 2 diabetes mellitus with foot ulcer

Interventions

Intervention 1: Intervention group: in this group, the patients will use TEBADERM dressing on their granulated wound daily. the dressing will be changed every 24 hours. Intervention 2: Control group:
Treatment - Devices
Intervention group: in this group, the patients will use TEBADERM dressing on their granulated wound daily. the dressing will be changed every 24 hours.
Control group: in this group, the patients will use standard dressing which it moisturizes with normal saline every 6 hours.

Sponsors

Iranian academic center for education culture and research
Lead Sponsor
Tebazist Polymer
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Chronic neuropathic diabetic foot ulcer (more than 6 weeks) with wound classification Wagner I & II full informed consent for recruitment in random allocation

Exclusion criteria

Exclusion criteria: Suspected osteomyelitis Evidence of severe Ischemia (ABI less than 0.8) ESR more than 70 Using corticosteroid or immuno-suppressor drug Chronic renal failure of Hemodialysis Charco Joint Suspected malignancy

Design outcomes

Primary

MeasureTime frame
Complete wound healing during study (at least 6 months). Timepoint: every month up to Month 6th. Method of measurement: inspection.;Changes of wound area. Timepoint: week 1, 2, 3, 4, 6 month 3, 4, 6. Method of measurement: photography.

Secondary

MeasureTime frame
IV Antibiotic therapy. Timepoint: every month up to month 6th. Method of measurement: clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamreza Esmaeeli Djavid

Iranian academic center for education culture and research

djavid@ut.ac.ir+98 21 6698 9110

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026